These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5698415)

  • 1. Plasma hydroxyproline in epilepsy.
    Langgård H
    Acta Neurol Scand; 1968; 44(3):387-90. PubMed ID: 5698415
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of phenobarbital, phenytoin, and anoxia on connective tissue of mice.
    Wilhjelm B; Langgård H
    Acta Neurol Scand; 1968; 44(5):643-50. PubMed ID: 5726736
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical significance of microsomal enzyme induction in the therapy of epileptic patients.
    Sotaniemi E; Arvela P; Hakkarainen H; Huhti E
    Ann Clin Res; 1970 Sep; 2(3):223-7. PubMed ID: 5473162
    [No Abstract]   [Full Text] [Related]  

  • 4. Interrelation at plasmatic level between antiepileptic drugs and lipids. Its implications in the efficiency of treatment in epilepsy. III. Changes induced by phenobarbital or/and diphenylhydantoin in serum lipids, lipoproteins and cortisol.
    Rogozea R; Florea-Ciocoiu V; Bălăiţă C; Luca N
    Neurol Psychiatr (Bucur); 1982; 20(2):89-100. PubMed ID: 7123121
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum calcium balance during early phase of diphenylhydantoin therapy.
    Reunanen MI; Sotaniemi EA; Hakkarainen HK
    Int J Clin Pharmacol Biopharm; 1976 Jul; 14(1):15-9. PubMed ID: 977200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate statistical methods in toxicology: application to the analysis of outpatient clinical data for diphenylhydantoin and phenobarbital in the treatment of epilepsy.
    Schaeffer DJ; Janardan KG; Somani SM; Easton D; Sherman D
    Toxicol Appl Pharmacol; 1980 Apr; 53(2):354-64. PubMed ID: 7394776
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemostasis in epileptic patients treated with anticonvulsant drugs].
    de Pasquet EG; Ghiggino CW; Toledo S; Tenzer SM
    Acta Neurol Latinoam; 1973; 19(1-4):67-77. PubMed ID: 4808368
    [No Abstract]   [Full Text] [Related]  

  • 8. [Panmyelopathy in combined epilepsy therapy using ethosuccimide, diphenylhydantoin, and phenobarbital in childhood].
    John K; Hermann J; Hässler A; John R
    Kinderarztl Prax; 1980 Jun; 48(6):304-10. PubMed ID: 7420870
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxazepam pharmacokinetics in patients with epilepsy treated long-term with phenytoin alone or in combination with phenobarbitone.
    Scott AK; Khir AS; Steele WH; Hawksworth GM; Petrie JC
    Br J Clin Pharmacol; 1983 Oct; 16(4):441-4. PubMed ID: 6626439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of psychotropic drugs on thrombocytes aggregation in patients with epilepsy].
    Morozov GV; Semenova NV; Slastenko OA; Mishchenko AL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(11):60-1. PubMed ID: 15581040
    [No Abstract]   [Full Text] [Related]  

  • 11. [Megaloblastic anemia due to anticonvulsant therapy].
    Mozziconacci P; Attai C; Pham-Huu-Trung ; Boisse J; Piussan C
    Ann Pediatr (Paris); 1967; 14(6):466-70. PubMed ID: 5618046
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Failure to confirm anticonvulsant hypomagnesaemia.
    Katz SH; Gerstman I; Lautenbacher HW; Hediger ML
    Br Med J; 1976 Feb; 1(6005):341. PubMed ID: 1247845
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum concentrations of diphenylhydantoin (phenytoin) and phenobarbital and their relation to therapeutic and toxic effects.
    Buchthal F; Svensmark O
    Psychiatr Neurol Neurochir; 1971; 74(2):117-36. PubMed ID: 5004709
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of seizure type on the efficacy of plasma concentrations of phenytoin, phenobarbital, and carbamazepine.
    Schmidt D; Einicke I; Haenel F
    Arch Neurol; 1986 Mar; 43(3):263-5. PubMed ID: 3947275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of phenytoin on phenobarbital pharmacokinetics in a patient with epilepsy.
    Kuranari M; Tatsukawa H; Seike M; Saikawa T; Ashikari Y; Kodama Y; Sakata T; Takeyama M
    Ann Pharmacother; 1995 Jan; 29(1):83-4. PubMed ID: 7711354
    [No Abstract]   [Full Text] [Related]  

  • 16. Gynecomastia in epileptics treated with phenobarbital, phenytoin and fluoresone: two case reports.
    Rossi L; Bonuccelli U; Marcacci G; Bindi A; De Scisciolo G; Arena R
    Ital J Neurol Sci; 1983 Jun; 4(2):207-10. PubMed ID: 6618859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diphenylhydantoin (Dilatin) and phenobarbital blood levels in epileptic children.
    Buchanan RA; Allen RJ
    Neurology; 1971 Aug; 21(8):866-71. PubMed ID: 5106302
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiepileptic drugs in developing countries.
    Trevathan E; Medina MT; Madrid A
    Lancet; 1998 Apr; 351(9110):1210-1. PubMed ID: 9643725
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of diphenylhydantoin and phenobarbital on the hydroxyproline contents of skin in pigs.
    Dam M; Langgård H
    Acta Neurol Scand; 1969; 45(4):502-6. PubMed ID: 5806781
    [No Abstract]   [Full Text] [Related]  

  • 20. Primidone, diphenylhydantoin and phenobarbital. Aspects of acute and chronic toxicity.
    Gallagher BB; Baumel IP; Mattson RH; Woodbury SG
    Neurology; 1973 Feb; 23(2):145-9. PubMed ID: 4734509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.